Form 4: iRhythm Holdings Grants RSUs to Chief Accounting Officer

iRhythm Holdings, Inc. Chief Accounting Officer Marc Rosenbaum was granted 2,508 Restricted Stock Units, vesting over four years.

Summary

• Marc Rosenbaum, Chief Accounting Officer of iRhythm Holdings, Inc. (IRTC), acquired 2,508 shares of Common Stock.
• The acquisition occurred on February 25, 2026, with a deemed execution date of February 25, 2026.
• These securities are Restricted Stock Units (RSUs), where each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
• The RSUs will vest 25% on March 1, 2027, and 25% on each subsequent one-year anniversary, contingent on Mr. Rosenbaum's continued service.
• Following this transaction, Mr. Rosenbaum beneficially owns a total of 17,522 shares of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, reflecting standard executive compensation practices that align management incentives with shareholder interests, though it is not a significant market-moving event.

Positives

• The grant of Restricted Stock Units aligns the Chief Accounting Officer's long-term interests with those of shareholders, as the value of the units is tied to the company's stock performance.
• RSU grants are a common and effective tool for executive retention and motivation, encouraging continued service and performance.

Negatives

• The RSUs have no immediate cash value and are subject to a multi-year vesting schedule, meaning the shares are not immediately available to the recipient.

Risks

• The RSUs are subject to forfeiture if the reporting person ceases to be a service provider to the company before the vesting dates.
• The ultimate value of the RSUs is dependent on the future market price of iRhythm Holdings, Inc. common stock, which can fluctuate.

Future Outlook

The vesting schedule for the Restricted Stock Units extends through March 1, 2030, indicating a long-term incentive for the Chief Accounting Officer to remain with the company and contribute to its sustained performance.

Industry Context

StockSavvy.ai notes that RSU grants are a common form of executive compensation in the medical technology and healthcare sectors, aligning management incentives with long-term shareholder value and promoting executive retention. This grant is consistent with typical compensation practices for senior officers in publicly traded companies.

Comparison to Industry Standards

• StockSavvy.ai observes that multi-year vesting schedules, such as the 25% annual vesting over four years seen here, are standard practice for RSU grants across comparable companies in the biotechnology and medical device industries, including firms like Medtronic or Abbott Laboratories, to promote executive retention and long-term performance.
• The grant of RSUs at a $0 acquisition price is typical for equity compensation, reflecting a contingent right to shares rather than an outright purchase.

Related Party Transactions

• The grant of 2,508 Restricted Stock Units to Chief Accounting Officer Marc Rosenbaum constitutes a related party transaction, which is a standard form of executive compensation designed to align management interests with shareholder value.

Stakeholder Impact

• Shareholders: The RSU grant aims to align the Chief Accounting Officer's interests with long-term shareholder value creation.
• Employees: The grant serves as an incentive for executive retention and performance, potentially fostering a stable leadership team.

Next Steps

• The vesting of 25% of the granted RSUs on March 1, 2027, subject to continued service.
• Subsequent annual vesting of 25% of the RSUs on March 1, 2028, March 1, 2029, and March 1, 2030.

Key Dates

Recommendation

This Form 4 reports a routine RSU grant to a Chief Accounting Officer, which is a standard component of executive compensation designed to align interests. It does not provide new information that would fundamentally alter the investment thesis for iRhythm Holdings, Inc., thus a 'hold' recommendation is appropriate.

Keywords

iRhythm Holdings, IRTC, Restricted Stock Units, RSU, Insider Transaction, Executive Compensation, Stock Grant, Form 4, Corporate Governance